Chinese herbal medicine for resistant hypertension: A systematic review

BMJ Open

Volumn 5, Issue 1, 2015, Pages

  Xiong, Xingjiang ^a   Li, Xiaoke ^b   Zhang, Yuqing ^c   Wang, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HERBACEOUS AGENT;

ARTICLE; BLOOD PRESSURE REGULATION; CHINESE HERB; CHINESE MEDICINE; DIASTOLIC BLOOD PRESSURE; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TABLET; BLOOD PRESSURE; DRUG EFFECTS; HYPERTENSION; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUGS, CHINESE HERBAL; HUMANS; HYPERTENSION; TREATMENT OUTCOME;

EID: 84922355202     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-005355     Document Type: Article

References (54)

1. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219.
2. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8). J Am Med Assoc 2014;311:507-20.
3. Ruilope LM. Current challenges in the clinical management of hypertension. Nat Rev Cardiol 2012;9:267-75.
4. Sarafidis PA, Georgianos P, Bakris GL. Resistant hypertension-its identification and epidemiology. Nat Rev Nephrol 2013;9:51-8.
5. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008;117:510-26.
6. Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012;125:1635-42.
7. Solini A, Ruilope LM. How can resistant hypertension be identified and prevented? Nat Rev Cardiol 2013;10:293-6.
8. Hanselin MR, Saseen JJ, Allen RR, et al. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension 2011;58:1008-13.
9. Brook RD, Appel LJ, Rubenfire M, et al. Beyond medications and diet: Alternative approaches to lowering blood pressure. Hypertension 2013;61:1360-83.
10. Dimeo F, Pagonas N, Seibert F, et al. Aerobic exercise reduces blood pressure in resistant hypertension. Hypertension 2012;60:653-8.
11. Wang J, Feng B, Yang XC, et al. Tai Chi for essential hypertension. Evid Based Complement Alternat Med 2013;2013:e215254, 1-10.
12. Lee MS, Pittler M, Guo RL, et al. Qigong for hypertension: A systematic review of randomized clinical trials. J Hypertens 2007;25:1525-32.
13. Posadzki P, Cramer H, Kuzdzal A, et al. Yoga for hypertension: A systematic review of randomized clinical trials. Complement Ther Med 2014;22:511-22.
14. Flachskampf FA, Gallasch J, Gefeller O, et al. Randomized trial of acupuncture to lower blood pressure. Circulation 2007;115:3121-9.
15. Xiong XJ, Liu W, Yang XC, et al. Moxibustion for essential hypertension. Complement Ther Med 2014;22:187-95.
16. Lee MS, Choi TY, Shin BC, et al. Cupping for hypertension: A systematic review. Clin Exp Hypertens 2010;32:423-5.
17. Xiong XJ, Li SJ, Zhang YQ. Massage therapy for essential hypertension: A systematic review. J Hum Hypertens 2014. doi:10.1038/jhh.2014.52.
18. Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension 2009;54:475-81.
19. Xiong XJ, Yang XC, Liu YM, et al. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertens Res 2013;36:570-9.
20. Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease. Arch Intern Med 1998;158:2225-34.
21. Wang J, Xiong XJ. Current situation and perspectives of clinical study in integrative medicine in China. Evid Based Complement Alternat Med 2012;2012:e268542, 1-11.
22. Wang J, Wang PQ, Xiong XJ. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Med 2012;2:e1000113, 1-5.
23. Mansoor GA. Herbs and alternative therapies in the hypertension clinic. Am J Hypertens 2001;14:971-5.
24. Xiong XJ, Yang XC, Liu W, et al. Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evid Based Complement Alternat Med 2013;2013:e275279, 1-13.
25. Vora CK, Mansoor GA. Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases. Curr Hypertens Rep 2005;7:275-80.
26. Zhang GP, Jin HM, Long JJ, et al. Effect of ganoderma lucidum (ling zhi) combined with hypotensor on blood sugar, plasma NO, microcirculation and hemorrheology in treatment of refractory hypertension. J Chin Micro 1999;3:75-8.
27. Liu SC, Wang HX, Hou XM, et al. Clinical research of modified qi ju dihuang decoction on resistant hypertension in elderly. J Emerg Tradit Chin Med 2011;20:1729-30.
28. Zhu ZP, Peng C. Effect of warming kidney yang therapy combined with western medicine on 23 cases of resistant hypertension. J Sichuan Tradit Chin Med 2012;30:83-4.
29. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, Version 5.1.0. The Cochrane Collaboration. 2011. http://handbook.cochrane.org/.
30. Huang SX, Liu YL, Huang J, et al. Long-term efficacy of salvia on patients with resistant hypertension complicated with hyperlipidemia. J Guangmin Tradit Chin Med 2010;25:1415-16.
31. Wang JY, Zheng X. Clinical observation of drinking for angelica and astragalus on refractory hypertension. J Hebei Tradit Chin Med 2013;35:817-19.
32. Zhang GP, Long JJ, Qian RZ, et al. Significance and changes of blood sugar, blood lipid, microcirculation and hemorheology during treatment of hypertension by linzhi combined with hypotensor. Chin J Micro 1997;7:34-6.
33. Zhang Q, Yang YM, Yu GY. Effects of gastrodin injection on blood pressure and vasoactive substances in treatment of old patients with refractory hypertension: A randomized controlled trial. J Chin Integr Med 2008;6:695-9.
34. Yan BY. Clinical observation of integrative medicine for refractory hypertension. J Guangmin Tradit Chin Med 2010;25:1263-4.
35. Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010;55:515-25.
36. Ernst E. 'First, do not harm' with complementary and alternative medicine. Trends Pharmacol Sci 2007;28:48-50.
37. Valli G, Giardina EG. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol 2002;39:1083-95.
38. Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet 2008;372:1938-40.
39. Xu H, Chen KJ. Integrative medicine: The experience from China. J Altern Complement Med 2008;14:3-7.
40. Wang J, Xiong XJ. Control strategy on hypertension in Chinese medicine. Evid Based Complement Alternat Med 2012;2012: e284847, 1-6.
41. Wang J, Xiong XJ. Evidence-based Chinese medicine for hypertension. Evid Based Complement Alternat Med 2013;2013: e978398, 1-12.
42. Wang J, Xiong XJ. Outcome measures of Chinese herbal medicine for hypertension: An overview of systematic reviews. Evid Based Complement Alternat Med 2012;2012:e697237, 1-10.
43. Xiong XJ, Liu W, Yang XC, et al. Ginkgo biloba extract for essential hypertension: A systemic review. Phytomedicine 2014;21:1131-6.
44. Xiong XJ, Yang XC, Feng B, et al. Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: A systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2013;2013:e982380, 1-9.
45. Wang J, Yao KW, Yang XC, et al. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: A systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2012;2012:e714805, 1-7.
46. Wang J, Feng B, Yang XC, et al. Tianma gouteng yin as adjunctive treatment for essential hypertension: A systematic review of randomized controlled trials. Evid Based Complement Alternat Med 2013;2013:e706125, 1-18.
47. Wang J, Yang XC, Feng B, et al. Is Yangxue Qingnao granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension? Evid Based Complement Alternat Med 2013;2013:e540613, 1-8.
48. Kinsel JF, Straus SE. Complementary and alternative therapeutics: rigorous research is needed to support claims. Annu Rev Pharmacol Toxicol 2003;43:463-84.
49. Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ 1999;319:160-1.
50. Hawkes D, Benhamu J. Pharmacological examination of TCM should be evidence based. Trends Pharmacol Sci 2014;35:111-12.
51. Sarris J. Chinese herbal medicine for sleep disorders: poor methodology restricts any clear conclusion. Sleep Med Rev 2012;16:493-5.
52. Chen W, Lin CD, Kang HJ, et al. Chinese herbal medicines for the treatment of Type A H1N1 Influenza: A systematic review of randomized controlled trials. PLoS One 2011;6:e28093, 1-7.
53. Rathbone J, Zhang L, Zhang M, et al. Chinese herbal medicine for schizophrenia. Cochrane Database Syst Rev 2005;11;(4): CD003444.
54. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trial. J Clin Epidemiol 2010;63:1-37.